Financials

Top 3 Financials Stocks That May Rocket Higher This Quarter
Wall Street's Most Accurate Analysts Give Their Take On 3 Financials Stocks With Over 12% Dividend Yields
Top 3 Financials Stocks That Could Blast Off In September
Wall Street's Most Accurate Analysts Give Their Take On 3 Financials Stocks With Over 12% Dividend Yields
Top 3 Financials Stocks That Could Blast Off In September
Top 4 Financials Stocks That May Crash This Month
Wall Street's Most Accurate Analysts Spotlight On 3 Financials Stocks With Over 12% Dividend Yields

Financials Recent News

EXCLUSIVE: Financials 'Looking Favorable' After JPMorgan Earnings — Market Strategist Jay Woods Says Sector 'Just Joining The Party'
The financial sector could outperform going forward after recent earnings reports and based on other catalysts, a market strategist tells Benzinga.
Financial Sector ETF Recoups All Of Its Post-Silicon Valley Bank Crash Losses As Major US Banks Report Booming Earnings
Warren Buffett's Late-Night Phone Call In 2008 May Have Sparked The Most Successful Yet Hated Program In The 'History of Mankind' – And Saved The Economy
In the midst of the financial crisis in October 2008, Berkshire Hathaway Inc. CEO Warren Buffett made a significant late-night phone call to the then-Treasury Secretary Henry "Hank" Paulson. Buffett aimed to share an idea that could potentially revive the struggling economy.
Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History
Clinical-stage biopharma company Seelos Therapeutics Inc. (NASDAQ: SEEL) reported financial results and clinical updates corresponding to the first quarter ended March 31, 2023. Quarterly numbers show:
Filament Health's Q1 2023 Financial Results, Material Uncertainty On The Horizon
Natural psychedelics drug developer Filament Health Corp. (OTCQB: FLHLF) shared its interim financial results and further business highlights for the first quarter ended March 31, 2023.
3 Worst-Performing Sectors: Which Stocks Are Dragging Returns During Debt Ceiling Crisis?
The U.S. stock market got off to a shaky start in May.
COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials
Mental healthcare biotech company advancing psilocybin therapy COMPASS Pathways plc (NASDAQ: CMPS) reported its financial results for the first quarter 2023 ended March 31, 2023 and updated on recent business and clinical progresses. In numbers:
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) reported the financial results for its first quarter ended March 31, 2023, and provided the period’s business highlights. Consolidated quarterly financials:
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
Clinical-stage biopharma company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has reported its unaudited financial results for the quarter ended March 31, 2023, and shared the period’s business highlights. Numbers show:
Here Are The Best Sector ETFs And Major Sector-Moving Stocks In April
As April draws to a close, it's the right time to look back at how the 11 S&P 500 sector ETFs fared over the month. The market as a whole was only slightly positive for the month, with the SPDR S&P 500 Trust ETF (ARCA: SPY) gaining 1.3%, although there were some 
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
The UK-based psychedelics biotech company Awakn Life Sciences Corp. (OTCQB: AWKNF) reported on its financial results and business highlights for the three and twelve months ended Jan. 31, 2023.  
Canada House Cannabis Reports Record Revenues, $15M Loss As It Changes FY End
Canada House Cannabis Group Inc. (CSE: CHV) reported on Monday its financial results for the 15 months ending July 31, 2022.
After A Tumultuous Q3, Warren Buffett Holds Onto 2 High Yielding Defensive Stocks
Warren Buffett, one of the most prolific Wall Street investors, is the fifth wealthiest in the world. The CEO and founder of Berkshire Hathaway Inc. (NYSE: BRK-A) boasts a net worth of more than $100 billion.
EnWave Reports 16% YoY Decrease In Q1 Revenue, Trims Expenses By 12%
EnWave Corporation (OTCPK: NWVCF) (TSX: ENW) (FSE:E4U) reported its consolidated interim financial results for the first quarter ended December 31, 2021.
Greenway Greenhouse Reports Second Consecutive Quarter Of Positive Adjusted EBITDA, Continues To Drive Towards Profitability
Greenway Greenhouse Cannabis Corporation (CSE: GWAY) has released its unaudited interim financial statements for the three and nine-month periods ending December 31, 2021, reporting a positive adjusted EBITDA for the second consecutive quarter.
COMPASS Pathways Posts Wider Net Loss In Q4, Gives Update On Psilocybin Research
COMPASS Pathways plc (NASDAQ: CMPS) reported its financial results for the fourth quarter and full year 2021 and gave an update on recent progress across its business.
Stem Holdings Q1 Revenue Drops Over 20% YoY, Plans To Focus On Oregon & California Operations
Vertically integrated cannabis operator Stem Holdings, Inc. (OTCQX: STMH) (CSE: STEM) announced its financial results for the fiscal first quarter 2022 ended December 31, 2021.
Why Is This Analyst Bullish About Financial Sector Stocks?
Financials have typically traded at about three-quarters of the S&P 500 multiple, so a price-to-earnings increase is likely for the entire financial sector, Oakmark Funds portfolio manager Bill Nygren said Wednesday on CNBCs "Squawk On The Street."
Earnings Roundup: GrowGen, Charlotte's Web, Vireo, Aleafia, Cresco
GrowGen Achieves Record Revenues
Earnings Roundup: Power REIT And MariMed Report Revenue Spikes, Willow Biosciences Explores CBG
Power REIT Q4 Revenue Increases 122% YoY, Eyes 'Accretive Acquisitions'
HEXO Achieves Positive EBITDA In Q2, Reports 94% YoY Increase In Revenue
Cannabis company Hexo Corp. (TSX:HEXO) (NYSE:HEXO) has achieved a positive adjusted EBITDA of $202,000 in the second quarter of 2021.
Earnings Roundup: Neptune, Item9, GW Pharmaceuticals
Neptune Revenue Declines 63% YoY, Shifts To CPG And Branded Products
Supreme Cannabis Reports Q2 Revenue Growth, Posts Adjusted EBITDA Of $3.6M
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) has generated roughly $21.7 in gross revenue and $18.3 million in net revenue in the second quarter of fiscal 2021.